Recent Updates
Recently added Catalysts
HSCS Positive Sentiment Score: 75/100

HeartSciences to Participate at the Inaugural EF Hutton Global Conference

Monday, May 8, 2023 2 min read
Key Takeaway: HeartSciences, a company focused on AI-based ECG technology, announced its participation in the EF Hutton Global Conference scheduled for May 10-11, 2023, in New York City. CEO Andrew Simpson will hold one-on-one meetings with attendees, offering insights into the company's advancements in heart disease detection. The event signifies a strategic opportunity for HeartSciences to enhance its visibility and partnerships within the healthcare sector. With the increasing importance of AI in medical technology, the conference presents a platform for sharing significant developments in electrocardiology.

Market Sentiment Analysis

POSITIVE FACTORS

  • HeartSciences will showcase its innovative AI technology at a significant industry conference.
  • The participation in the EF Hutton Global Conference highlights the company's commitment to advancing ECG technology.
  • The CEO's one-on-one meetings provide opportunities for networking and potential collaborations.

Full Press Release Details

Southlake, Texas, May 08, 2023 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-based medical technology company focused on transforming ECGs/EKGs to save lives through the early  detection of heart disease, today announces that CEO, Andrew Simpson, will participate at the Inaugural EF Hutton Global Conference being held May 10 – 11, 2023, at the Plaza Hotel in New York City.
Mr. Simpson will be holding one-on-one meetings on May 11, 2023. Registered attendees of the conference are encouraged to request a meeting with Mr. Simpson by contacting your EF Hutton representative.
For more information, please visit:https://efhconference.com/
Heart Test Laboratories, Inc. d/b/a HeartSciences is a next-generation, AI electrocardiogram (AI ECG) company focused on using AI to transform the ECG (also known as the EKG) to save lives through earlier detection of heart disease. Millions of ECGs are performed every week and AI is creating a new era of opportunity for the ECG with recent AI ECG applications described as “some of the most significant advances in electrocardiography since its inception1.” The Company’s objective is to become a fixture in front-line healthcare settings to help physicians make better and earlier referral decisions for at-risk patients.
For more information, please visit: visit: https://www.heartsciences.com
Twitter: @HeartSciences
1 - Khurram Nasir, MD, MPH, MSC,et. al., Journal of American College of Cardiology Editorial Comment Volume 76 Number 8 2020.
For Investor and Media Inquiries, please contact:
Email: scotta@coreir.com
Phone: +1-737-414-9213 (US)
Email: investorrelations@heartsciences.com

Tags

Heart Test Laboratories
EF Hutton Global Conference

Frequently Asked Questions

Who is the CEO of HeartSciences?

The CEO of HeartSciences is Andrew Simpson.

When is the EF Hutton Global Conference?

The conference is held on May 10-11, 2023.

What technology does HeartSciences focus on?

HeartSciences focuses on AI-based electrocardiograms (ECGs) to detect heart disease.

How can attendees meet with Andrew Simpson?

Attendees can request a meeting by contacting their EF Hutton representative.

What is HeartSciences' main goal?

Their goal is to aid in the early detection of heart disease in healthcare settings.

Tags: HSCS Viatris Investor Conferences Healthcare HeartSciences AI ECG heart disease EF Hutton medical technology
Last updated: May 8, 2023